Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Chaoju Eye Care Holdings Ltd. (2219) Stock Price & Analysis

2 Followers

2219 Stock Chart & Stats

HK$2.42HK$0.00(0.00%)
At close: 4:00 PM GMT+8
HK$2.4HK$2.5HK$2.6Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 2.38 - HKD 2.42
52-Week Range
HKD 2.20 - HKD 3.14
Previous Close
HKD 2.42
Volume
N/A
Average Volume (3M)
300.69K
Market Cap
HKD 1.69B
Enterprise Value
HKD 374.35M
Total Cash (Recent Filing)
HKD 1.40B
Total Debt (Recent Filing)
HKD 249.02M
Price to Earnings (P/E)
8.6
Beta
0.53
Next Earnings
Mar 30, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
May 14, 2026
Dividend Yield
10.03%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Low leverage and a large equity base give Chaoju financial resilience, reducing balance-sheet strain and preserving capacity to fund hospitals, clinics, and other operating needs through a weaker earnings period. This supports stability over the next several quarters.

Healthy Profitability

Healthy 2025 gross, EBIT, and net margins show the ophthalmology network remains economically profitable despite recent softness. That profitability can support ongoing clinical operations and reinvestment, while providing a cushion if demand or revenue growth remains subdued.

Positive Operating Cash Flow

Positive operating cash flow of about RMB339 million confirms the company continues converting its medical-services operations into cash. Although conversion weakened, ongoing cash generation provides internal funding for operations and reduces reliance on external financing.

Bears Say

Revenue Contraction

Revenue declined 3.2% in 2025 after only modest growth in 2024, signaling weakened top-line momentum. If this persists, slower expansion could limit operating leverage and make it harder to sustain profit growth across the hospital and clinic network.

Margin Compression

Net margin fell to about 13.5% in 2025 from roughly 16.7%–19.0% in 2022–2023, while EBIT margin also compressed. Continued margin erosion would reduce earnings resilience and leave less profit available to reinvest in the ophthalmic services platform.

Free Cash Flow Volatility

Free cash flow fell about 59.8% year over year to roughly RMB113 million, with FCF only one-third of net income. Weaker cash conversion and higher cash outflows can constrain shareholder distributions and internally funded investment, even while reported profit remains positive.

Chaoju Eye Care Holdings Ltd. News

2219 FAQ

What was Chaoju Eye Care Holdings Ltd.’s price range in the past 12 months?
Chaoju Eye Care Holdings Ltd. lowest stock price was HK$2.20 and its highest was HK$3.14 in the past 12 months.
What is Chaoju Eye Care Holdings Ltd.’s market cap?
Chaoju Eye Care Holdings Ltd.’s market cap is HK$1.69B.
When is Chaoju Eye Care Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Chaoju Eye Care Holdings Ltd.’s earnings last quarter?
Chaoju Eye Care Holdings Ltd. released its earnings results on Aug 28, 2026. The company reported HK$0.165 earnings per share for the quarter.
Is Chaoju Eye Care Holdings Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Chaoju Eye Care Holdings Ltd. pay dividends?
Chaoju Eye Care Holdings Ltd. pays an annual dividend of HK$0.242 which represents an annual dividend yield of 10.03%. See more information on Chaoju Eye Care Holdings Ltd. dividends here
What is Chaoju Eye Care Holdings Ltd.’s EPS estimate?
Chaoju Eye Care Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chaoju Eye Care Holdings Ltd. have?
Chaoju Eye Care Holdings Ltd. has 701,460,000 shares outstanding.
What happened to Chaoju Eye Care Holdings Ltd.’s price movement after its last earnings report?
Chaoju Eye Care Holdings Ltd. reported an EPS of HK$0.165 in its last earnings report. Following the earnings report the stock price went up 0.395%.
Which hedge fund is a major shareholder of Chaoju Eye Care Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:2219
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology